Somatic Mosaic Mutation Gradient Detected in Trace Brain Tissue From Stereo-EEG Depth Electrodes.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
03 Oct 2022
Historique:
received: 16 03 2022
accepted: 09 09 2022
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 4 10 2022
Statut: aheadofprint

Résumé

Mosaic pathogenic variants restricted to brain are increasingly recognized as a cause of focal epilepsies. We aimed to identify a mosaic pathogenic variant and its anatomical gradient in brain DNA derived from trace tissue on explanted stereo-electroencephalography (SEEG) electrodes. We studied a patient with non-lesional multifocal epilepsy undergoing pre-surgical evaluation with SEEG. Following explantation, electrodes were divided into 3 pools based on their brain location (right posterior quadrant, left posterior quadrant, hippocampus/temporal neocortex). Tissue from each pool was processed and DNA whole genome amplified prior to high-depth exome sequencing. Droplet digital PCR was performed to quantify mosaicism. Brain-specific GFAP protein assay enabled cell-of-origin analysis. We demonstrated a mosaic gradient for a novel pathogenic This study demonstrates proof-of-concept that mosaic gradients of pathogenic variants can be established using trace tissue from explanted SEEG electrodes.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Mosaic pathogenic variants restricted to brain are increasingly recognized as a cause of focal epilepsies. We aimed to identify a mosaic pathogenic variant and its anatomical gradient in brain DNA derived from trace tissue on explanted stereo-electroencephalography (SEEG) electrodes.
MATERIAL AND METHODS METHODS
We studied a patient with non-lesional multifocal epilepsy undergoing pre-surgical evaluation with SEEG. Following explantation, electrodes were divided into 3 pools based on their brain location (right posterior quadrant, left posterior quadrant, hippocampus/temporal neocortex). Tissue from each pool was processed and DNA whole genome amplified prior to high-depth exome sequencing. Droplet digital PCR was performed to quantify mosaicism. Brain-specific GFAP protein assay enabled cell-of-origin analysis.
RESULTS RESULTS
We demonstrated a mosaic gradient for a novel pathogenic
CONCLUSIONS CONCLUSIONS
This study demonstrates proof-of-concept that mosaic gradients of pathogenic variants can be established using trace tissue from explanted SEEG electrodes.

Identifiants

pubmed: 36192176
pii: WNL.0000000000201469
doi: 10.1212/WNL.0000000000201469
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 American Academy of Neurology.

Auteurs

Zimeng Ye (Z)

Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Australia.

Mark F Bennett (MF)

Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Australia.
Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Department of Medical Biology, The University of Melbourne, Parkville, Australia.

Andrew Neal (A)

Department of Neurology, Royal Melbourne Hospital, Parkville, Australia.
Department of Neurology, Alfred Hospital, Melbourne, Australia.
Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
Department of Neurosciences, The Central Clinical School, Monash University, Melbourne, Australia.
Department of Neurology, St Vincent's Hospital, Fitzroy, Australia.

Joshua A Laing (JA)

Department of Neurology, Alfred Hospital, Melbourne, Australia.
Department of Neurosciences, The Central Clinical School, Monash University, Melbourne, Australia.

Martin K Hunn (MK)

Department of Neurosurgery, The Alfred Hospital, Melbourne, Australia.

Thanomporn Wittayacharoenpong (T)

Department of Neurology, Alfred Hospital, Melbourne, Australia.
Department of Neurosciences, The Central Clinical School, Monash University, Melbourne, Australia.

Marian Todaro (M)

Department of Neurology, Alfred Hospital, Melbourne, Australia.
Department of Neurosciences, The Central Clinical School, Monash University, Melbourne, Australia.

Sheila K Patel (SK)

Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Australia.
Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.

Melanie Bahlo (M)

Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Department of Medical Biology, The University of Melbourne, Parkville, Australia.

Patrick Kwan (P)

Department of Neurology, Royal Melbourne Hospital, Parkville, Australia.
Department of Neurology, Alfred Hospital, Melbourne, Australia.
Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
Department of Neurosciences, The Central Clinical School, Monash University, Melbourne, Australia.

Terence J O'Brien (TJ)

Department of Neurology, Royal Melbourne Hospital, Parkville, Australia.
Department of Neurology, Alfred Hospital, Melbourne, Australia.
Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
Department of Neurosciences, The Central Clinical School, Monash University, Melbourne, Australia.

Ingrid E Scheffer (IE)

Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Australia.
Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Australia.

Samuel F Berkovic (SF)

Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Australia.
Bladin-Berkovic Comprehensive Epilepsy Program, Department of Neurology, Austin Health, Heidelberg, Australia.

Piero Perucca (P)

Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Australia.
Department of Neurology, Royal Melbourne Hospital, Parkville, Australia.
Department of Neurology, Alfred Hospital, Melbourne, Australia.
Department of Neurosciences, The Central Clinical School, Monash University, Melbourne, Australia.
Bladin-Berkovic Comprehensive Epilepsy Program, Department of Neurology, Austin Health, Heidelberg, Australia.

Michael S Hildebrand (MS)

Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Australia michael.hildebrand@unimelb.edu.au.
Murdoch Children's Research Institute, Parkville, Australia.

Classifications MeSH